Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae
Authors:
- Dylan R PillaiDPDylan R Pillai
- Dea ShahinasDSDea Shahinas
- Alla BuzinaABAlla Buzina
- Remy A PollockRPRemy A Pollock
- Rachel LauRLRachel Lau
- Krishna KhairnarKKKrishna Khairnar
- Andrew WongAWAndrew Wong
- David J FarrellDFDavid J Farrell
- Karen GreenKGKaren Green
- Allison McGeerAMAllison McGeer
- Donald E LowDLDonald E Low
Open Access
- 1 January 2009
- journal article
- research article
- Published by Springer Nature in BMC Genomics
- Vol. 10 (1) , 642
Abstract
Emergence of multi-drug resistant (MDR) serotype 19A Streptococcus pneumoniae (SPN) is well-documented but causal factors remain unclear. Canadian SPN isolates (1993-2008, n = 11,083) were serotyped and in vitro susceptibility tested. A subset of MDR 19A were multi-locus sequence typed (MLST) and representative isolates' whole genomes sequenced. MDR 19A increased in the post-PCV7 era while 19F, 6B, and 23F concurrently declined. MLST of MDR 19A (n = 97) revealed that sequence type (ST) 320 predominated. ST320 was unique amongst MDR 19A in that its minimum inhibitory concentration (MIC) values for penicillin, amoxicillin, ceftriaxone, and erythromycin were higher than for other ST present amongst post-PCV7 MDR 19A. DNA sequencing revealed that alleles at key drug resistance loci pbp2a, pbp2x, pbp2b, ermB, mefA/E, and tetM were conserved between pre-PCV7 ST 320 19F and post-PCV7 ST 320 19A most likely due to a capsule switch recombination event. A genome wide comparison of MDR 19A ST320 with MDR 19F ST320 identified 822 unique SNPs in 19A, 61 of which were present in antimicrobial resistance genes and 100 in virulence factors. Our results suggest a complex genetic picture where high-level drug resistance, vaccine selection pressure, and SPN mutational events have created a "perfect storm" for the emergence of MDR 19A.Keywords
This publication has 38 references indexed in Scilit:
- Temporal Trends of Invasive Streptococcus pneumoniae Serotypes and Antimicrobial Resistance Patterns in Spain from 1979 to 2007Journal of Clinical Microbiology, 2009
- Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniaeClinical Microbiology and Infection, 2009
- Changes of serotype and genotype in Streptococcus pneumoniae isolates from a Korean hospital in 2007Diagnostic Microbiology and Infectious Disease, 2009
- Population Snapshot of Streptococcus pneumoniae Serotype 19A Isolates before and after Introduction of Seven-Valent Pneumococcal Vaccination for French ChildrenJournal of Clinical Microbiology, 2009
- A New Twist on an Old ProblemThe Pediatric Infectious Disease Journal, 2009
- Impact of conjugate pneumococcal vaccines on antibiotic resistanceThe Lancet Infectious Diseases, 2008
- Emergence ofStreptococcus pneumoniaeSerotypes 19A, 6C, and 22F and Serogroup 15 in Cleveland, Ohio, in Relation to Introduction of the Protein‐Conjugated Pneumococcal VaccineClinical Infectious Diseases, 2008
- Temporal and Spatial Distribution of Clonal Complexes of Streptococcus pneumoniae Isolates Resistant to Multiple Classes of Antibiotics in Belgium, 1997 to 2004Antimicrobial Agents and Chemotherapy, 2008
- Population Snapshot of EmergentStreptococcus pneumoniaeSerotype 19A in the United States, 2005The Journal of Infectious Diseases, 2008
- Emergence of 19A as Virulent and Multidrug Resistant Pneumococcus in Massachusetts Following Universal Immunization of Infants With Pneumococcal Conjugate VaccineThe Pediatric Infectious Disease Journal, 2007